EDU 38 - Hypofractionation for Soft-Tissue Sarcoma

Moderator(s)

• 

  Daniel Indelicato, MD, FASTRO

  University of Florida Department of Radiation Oncology
  Jacksonville, Florida, United States

Modern trends throughout radiation oncology have favored short-course hypofractionated regimens which are frequently more cost-effective and convenient for patients. Over the past two years, multiple prospective studies have emerged supporting hypofractionation in soft tissue sarcoma. These studies include a variety of fractionation, techniques and endpoints. There is a need to both increase awareness of this new approach and synthesize the data for a general audience. In this session, a panel of experts will review the data supporting hypofractionation for STS. This includes the positive benefits patients might derive as well as limitations of our current knowledge base. This educational session will include practical highlights, including indications for and techniques applied in published studies of hypofractionation, including patient selection, dose and margins.

Presentations:

• 8:00 AM – 8:02 AM ET

  Introductions
  

  Speaker: Daniel Indelicato, MD, FASTRO – University of Florida Department of Radiation Oncology
• 8:02 AM – 8:17 AM ET

  Long-Term Oncologic Outcomes from a Phase II, Prospective, 5-Fraction Pre-Operative Radiation Therapy Trial in Patients with Localized Soft Tissue Sarcoma
  

  Speaker: Manpreet Bedi, MD, MS – Medical College of Wisconsin Affiliated Hospitals
• 8:17 AM – 8:32 AM ET

  Ultra-Hypofractionated Preoperative Radiation Therapy for Soft Tissue Sarcoma
  

  Speaker: Anusha Kalbasi, MD – Stanford University
• 8:32 AM – 8:47 AM ET

  Hypofractionated, 3-Week, Preoperative Radiotherapy for Patients with Soft Tissue Sarcomas (HYPORT-STS)
  

  Speaker: Andrew Bishop, MD – MD Anderson Cancer Center
• 8:47 AM – 9:00 AM ET

  Questions and Answers
  

  Speaker: Daniel Indelicato, MD, FASTRO – University of Florida Department of Radiation Oncology